arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

DocGo Inc.

DCGO
$0.24 ▼ -0.02 (-6.79%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
24 Visible periods
33 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

DocGo Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). On the positive side, Debt to Equity remains strong. Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $23.7M
Dividend Yield —
Revenue Growth -8.7% ↗
Op. Margin -24.4% →
ROIC -15.1% ↘
FCF / Share $-0.10 ↘
Trailing P/E —
Price / Book 0.2x
FCF Yield —
Debt / Equity 0.00
info Valuation on last close. End-of-day price, Nov 5, 2026.

24-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$73.42M
↓ -8.7% —
Net Income Profit after all expenses
$-14.76M
↓ -57.0% —
Operating Margin Operating profit as % of sales
-24.4%
↑ +1.4% 5th
FCF / Share Free cash flow per share
$-0.10
↓ -87.8% —
Long-Term Debt Long-term obligations
$207.37K
↓ -6.2% —
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
23
Returns
6
Financial Health ↓
54
Cash Quality ↑
17

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 6 years · 24 quarters